Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction

Abstract

Carvedilol reduced mortality rates and heart failure in those with higher pretreatment BNP levels but lesser activation of plasma NE. Neurohumoral profiling may guide introduction of beta-blockade in heart failure.